JARID2 acts as a tumor suppressor and plays a crucial role in the leukemic transformation of myeloid neoplasms34, and its deletion promotes an ineffective hematopoietic differentiation35, suggesting that the low activity of this regulon may negatively impact the hematopoietic differentiation of these patients. Here, JARID2 is linked to neoplasm.